Cargando…
Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284868/ http://dx.doi.org/10.1186/bcr2265 |
_version_ | 1782351480821383168 |
---|---|
author | Pusztai, L |
author_facet | Pusztai, L |
author_sort | Pusztai, L |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4284868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42848682015-01-15 Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design Pusztai, L Breast Cancer Res Oral Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284868/ http://dx.doi.org/10.1186/bcr2265 Text en Copyright © 2009 BioMed Central Ltd. |
spellingShingle | Oral Presentation Pusztai, L Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title | Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title_full | Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title_fullStr | Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title_full_unstemmed | Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title_short | Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
title_sort | molecular heterogeneity of breast cancer: implications for treatment and clinical trial design |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284868/ http://dx.doi.org/10.1186/bcr2265 |
work_keys_str_mv | AT pusztail molecularheterogeneityofbreastcancerimplicationsfortreatmentandclinicaltrialdesign |